The current status of treatment for colorectal cancer in China: A systematic review
- PMID: 28984783
- PMCID: PMC5738019
- DOI: 10.1097/MD.0000000000008242
The current status of treatment for colorectal cancer in China: A systematic review
Abstract
Background: Colorectal cancer (CRC) is one of the most common cancers all over the world, but its epidemiology is obviously different in various regions.
Methods: The treatment of CRC also has varying characteristics due to differences in economy, geography, disease onset, chemotherapy, and other factors, although international guidelines are used to guide the treatment of CRC in China.
Results: This paper summarizes the current status of CRC treatment, including surgical therapy, neoadjuvant radiotherapy and chemotherapy, postoperative chemotherapy, targeted therapy, maintenance therapy, and immunotherapy, according to the clinical situation in China, so as to provide better therapy and improve clinical practice for patients with CRC.
Conclusion: This research shows that the treatment of colorectal cancer continues to progress, and the patient's efficacy and quality of life have improved.
Conflict of interest statement
The authors declare that they have no conflict of interest.
References
-
- Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012. CA Cancer J Clin 2015;65:87–108. - PubMed
-
- Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 2015;136:E359–86. - PubMed
-
- Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015. CA Cancer J Clin 2016;66:115–32. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical